General Biologicals Debuts Circulating Tumor Cell Cancer Detection Products
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read More
Search Results for: prostate cancer
New Method for Noninvasive Detection of Circulating Tumor Cells in Blood
The technique uses two laser sources and detectors to mitigate noise and autofluorescence, and may help detect fluorescent tags.
Read More
Quest Launches Prostate Cancer Test to Improve Diagnosis and Grading
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.
Read More
EDP Biotech, New Day Diagnostics Announce Merger
EDP Biotech Corp. and New Day Diagnostics LLC announced their strategic merger, joining together to focus on the expedited development and commercialization of diagnostic tests.
Read More
AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read More